Preliminary evidence for lowered basal cortisol in a naturalistic sample of methamphetamine polydrug users

Experimental and Clinical Psychopharmacology

Volumn 20, Issue 6, 2012, Pages 497-503

  Carson, Dean S ^a,b   Bosanquet, David P ^a   Carter, C Sue ^c   Pournajafi Nazarloo, Hossein ^c   Blaszczynski, Alex ^a   McGregor, Iain S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b STANFORD UNIVERSITY   (United States)

^c RTI INTERNATIONAL   (United States)

Author keywords

Addiction; Arginine vasopressin; Cortisol; Methamphetamine; Oxytocin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; ARGIPRESSIN; DRONABINOL; HYDROCORTISONE; METHAMPHETAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISORIENTATION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMPULSIVENESS; INTRAVENOUS DRUG ABUSE; MALE; MANIA; MENTAL DISEASE; MULTIPLE DRUG ABUSE; NEUROENDOCRINE SYSTEM; OXYTOCIN BLOOD LEVEL; SUBSTANCE ABUSE; VASOPRESSIN BLOOD LEVEL;

ADULT; AMPHETAMINE-RELATED DISORDERS; ARGININE VASOPRESSIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYDROCORTISONE; MALE; METHAMPHETAMINE; MIDDLE AGED; OXYTOCIN;

EID: 84874461612     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0029976     Document Type: Article

References (47)

1. Adinoff, B., Krebaum, S. R., Chandler, P. A., Ye, W., Brown, M. B., & Williams, M. J. (2005). Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, Part 1: Adrenocortical and pituitary glucocorticoid responsiveness. Alcoholism: Clinical and Experimental Research, 29, 517-527. doi:10.1097/01.ALC .0000158940.05529.0A
2. Aouizerate, B., Ho, A., Schluger, J. H., Perret, G., Borg, L., Le Moal, M., Kreek, M. J. (2006). Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: Dose-response to dexamethasone suppression. Addiction Biology, 11, 84-96. doi:10.1111/j.1369-1600.2006.00006.x
3. Baracz, S. J., Rourke, P. I., Pardey, M. C., Hunt, G. E., McGregor, I. S., & Cornish, J. L. (2012). Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamineinduced conditioned place preference. Behavioural Brain Research, 228, 185-193.
4. Bosanquet, D., MacDougall, H. G., Rogers, S. J., Starmer, G. A., McKetin, R., Blaszczynski, A., & McGregor, I. S. (2012). Driving on ice: Impaired driving skills in current methamphetamine users. Psychopharmacology. Advance online publication. doi:10.1007/s00213-012-2805-y
5. Campbell, G. A., & Rosner, M. H. (2008). The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. Clinical Journal of the American Society of Nephrology, 3, 1852-1860. doi:10.2215/CJN.02080508
6. Carson, D. S., Cornish, J. L., Guastella, A. J., Hunt, G. E., & McGregor, I. S. (2010). Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamineseeking behaviour in rats. Neuropharmacology, 58, 38-43. doi:10.1016/j.neuropharm.2009.06.018
7. Carson, D. S., Hunt, G. E., Guastella, A. J., Barber, L., Cornish, J. L., Arnold, J. C.,...McGregor, I. S. (2010). Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addiction Biology, 15, 448-463. doi:10.1111/j.1369-1600.2010.00247.x
8. Degenhardt, L., & Topp, L. (2003). 'Crystal meth' use among polydrug users in Sydney's dance party subculture: Characteristics, use patterns and associated harms. International Journal of Drug Policy, 14, 17-24. doi:10.1016/S0955-3959(02)00200-1
9. Dingemans, P. M., Linszen, D. H., Lenior, M. E., & Smeets, R. M. (1995). Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E). Psychopharmacology, 122, 263-267. doi:10.1007/BF02246547
10. Dumont, G. J., Sweep, F. C., van der Steen, R., Hermsen, R., Donders, A. R., Touw, D. J.,...Verkes, R. J. (2009). Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4methylenedioxymethamphetamine) administration. Social Neuroscience, 4, 359-366. doi:10.1080/17470910802649470
11. Frank, E., & Landgraf, R. (2008). The vasopressin system-From antidiuresis to psychopathology. European Journal of Pharmacology, 583, 226-242. doi:10.1016/j.ejphar.2007.11.063
12. Goldman, M. B. (2009). The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness. Brain Research Reviews, 61, 210-220. doi:10.1016/j.brainresrev .2009.06.004
13. Harris, D. S., Reus, V. I., Wolkowitz, O. M., Mendelson, J. E., & Jones, R. T. (2003). Altering cortisol level does not change the pleasurable effects of methamphetamine in humans. Neuropsychopharmacology, 28, 1677-1684. doi:10.1038/sj.npp.1300223
14. Herring, N. R., Schaefer, T. L., Tang, P. H., Skelton, M. R., Lucot, J. P., Gudelsky, G. A.,...Williams, M. T. (2008). Comparison of timedependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats. BMC Neuroscience, 9, 49. doi:10.1186/1471-2202-9-49
15. Hysek, C. M., Domes, G., & Liechti, M. E. (2012). MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions. Psychopharmcology, 222, 293-302. doi:10.1007/s00213-012-2645-9
16. Johns, J. M., McMurray, M. S., Joyner, P. W., Jarrett, T. M., Williams, S. K., Cox, E. T.,...Walker, C. H. (2010). Effects of chronic and intermittent cocaine treatment on dominance, aggression, and oxytocin levels in post-lactational rats. Psychopharmacology, 211, 175-185. doi: 10.1007/s00213-010-1877-9
17. Kaye, S., Darke, S., Duflou, J., & McKetin, R. (2008). Methamphetaminerelated fatalities in Australia: Demographics, circumstances, toxicology and major organ pathology. Addiction, 103, 1353-1360. doi:10.1111/j .1360-0443.2008.02231.x
18. Koob, G., & Kreek, M. J. (2007). Stress, dysregulation of drug reward pathways, and the transition to drug dependence. American Journal of Psychiatry, 164, 1149-1159. doi:10.1176/appi.ajp.2007.05030503
19. Krasnova, I. N., & Cadet, J. L. (2009). Methamphetamine toxicity and messengers of death. Brain Research Reviews, 60, 379-407. doi: 10.1016/j.brainresrev.2009.03.002
20. Landgraf, R., & Neumann, I. D. (2004). Vasopressin and oxytocin release within the brain: A dynamic concept of multiple and variable modes of neuropeptide communication. Frontiers in Neuroendocrinology, 25, 150-176. doi:10.1016/j.yfrne.2004.05.001
21. Lapworth, K., Dawe, S., Davis, P., Kavanagh, D., Young, R., & Saunders, J. (2009). Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users. Addictive Behaviors, 34, 380-385. doi:10.1016/j.addbeh.2008.11.014
22. Lee, M. S., Yang, J. W., Ko, Y. H., Han, C., Kim, S. H., Lee, M. S.,... Jung, J. K. (2008). Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder. Child Psychiatry and Human Development, 39, 201-9. doi: 10.1007/s10578-007-0081-6
23. Lee, N. K., & Rawson, R. A. (2008). A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug and Alcohol Review, 27, 309-317. doi:10.1080/09595230801919494
24. Li, C., Wang, W., Summer, S. N., Westfall, T. D., Brooks, D. P., Falk, S., & Schrier, R. W. (2008). Molecular mechanisms of antidiuretic effect of oxytocin. Journal of the American Society of Nephrology, 19, 225-232. doi:10.1681/ASN.2007010029
25. Light, K. C., Grewen, K. M., Amico, J. A., Boccia, M., Brownley, K. A., & Johns, J. M. (2004). Deficits in plasma oxytocin responses and increased negative affect, stress, and blood pressure in mothers with cocaine exposure during pregnancy. Addictive Behaviors, 29, 1541-1564. doi:10.1016/j.addbeh.2004.02.062
26. Ludwig, M., & Leng, G. (2006). Dendritic peptide release and peptidedependent behaviours. Nature Reviews Neuroscience, 7, 126-136. doi: 10.1038/nrn1845
27. Madden, L. J., Flynn, C. T., Zandonatti, M. A., May, M., Parsons, L. H., Katner, S. N.,...Fox, H. S. (2005). Modeling human methamphetamine exposure in nonhuman primates: Chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities. Neuropsychopharmacology, 30, 350-359. doi:10.1038/sj.npp.1300575
28. Mantsch, J. R., Yuferov, V., Mathieu-Kia, A. M., Ho, A., & Kreek, M. J. (2003). Neuroendocrine alterations in a high-dose, extended-access rat self-administration model of escalating cocaine use. Psychoneuroendocrinology, 28, 836-862. doi:10.1016/S0306-4530(02)00088-4
29. McGregor, I. S., Callaghan, P. D., & Hunt, G. E. (2008). From ultrasocial to antisocial: A role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? British Journal of Pharmacology, 154, 358-368. doi:10.1038/bjp.2008.132
30. Mello, N. K. (2010). Hormones, nicotine, and cocaine: Clinical studies. Hormones and Behavior, 58, 57-71. doi:10.1016/j.yhbeh.2009.10.003
31. Meredith, C. W., Jaffe, C., Ang-Lee, K., & Saxon, A. J. (2005). Implications of chronic methamphetamine use: A literature review. Harvard Review of Psychiatry, 13, 141-154. doi:10.1080/10673220591003605
32. Moeller, F. G., Barratt, E. S., Dougherty, D. M., Schmitz, J. M., & Swann, A. C. (2001). Psychiatric aspects of impulsivity. American Journal of Psychiatry, 158, 1783-1793. doi:10.1176/appi.ajp.158.11.1783
33. Neumann, I., Ludwig, M., Engelmann, M., Pittman, Q. J., & Landgraf, R. (1993). Simultaneous microdialysis in blood and brain: Oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat. Neuroendocrinology, 58, 637-645. doi:10.1159/000126604
34. Qi, J., Han, W. Y., Yang, J. Y., Wang, L. H., Dong, Y. X., Wang, F.,... Wu, C. F. (2012). Oxytocin regulates changes of extracellular glutamate and GABA levels induced by methamphetamine in the mouse brain. Addiction Biology, 17, 758-769. doi:10.1111/j.1369-1600.2012.00439.x
35. Qi, J., Yang, J. Y., Song, M., Li, Y., Wang, F., & Wu, C. F. (2008). Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice. NaunynSchmiedeberg's Archives of Pharmacology, 376, 441-448. doi:10.1007/s00210-007-0245-8
36. Qi, J., Yang, J.-Y., Wang, F., Zhao, Y.-N., Song, M., & Wu, C.-F. (2009). Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology, 56, 856-865. doi:10.1016/j.neuropharm.2009.01.010
37. Ranganathan, M., Braley, G., Pittman, B., Cooper, T., Perry, E., Krystal, J., & D'Souza, D. C. (2009). The effects of cannabinioids on serum cortisol and prolactin in humans. Psychopharmacology, 203, 737-744. doi: 10.1007/s00213-008-1422-2
38. Rubin, L. H., Carter, C. S., Drogos, L., Pournajafi-Nazarloo, H., Sweeney, J. A., & Maki, P. M. (2010). Peripheral oxytocin is associated with reduced symptom severity in schizophrenia. Schizophrenia Research, 124, 13-21. doi:10.1016/j.schres.2010.09.014
39. Sarnyai, Z., Dhabhar, F. S., McEwen, B. S., & Kreek, M. J. (1998). Neuroendocrine-related effects of long-term, 'binge' cocaine administration: Diminished individual differences in stress-induced corticosterone response. Neuroendocrinology, 68, 334-344. doi:10.1159/000054382
40. Schaefer, T. L., Grace, C. E., Gudelsky, G. A., Vorhees, C. V., & Williams, M. T. (2010). Effects on plasma corticosterone levels and brain serotonin from interference with methamphetamine-induced corticosterone release in neonatal rats. Stress, 13, 469-480.
41. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E.,...Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl 20), 22-33.
42. Sobell, L. C., Sobell, M. B., Leo, G. I., & Cancilla, A. (1988). Reliability of a timeline method: Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. British Journal of Addiction, 83, 393-402. doi:10.1111/j.1360-0443.1988 .tb00485.x
43. Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005). Mechanisms of neurotransmitter release by amphetamines: A review. Progress in Neurobiology, 75, 406-433. doi:10.1016/j.pneurobio.2005.04.003
44. Thompson, M. R., Callaghan, P. D., Hunt, G. E., Cornish, J. L., & McGregor, I. S. (2007). A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy"). Neuroscience, 146, 509-514. doi:10.1016/j.neuroscience.2007 .02.032
45. van Nieuwenhuijzen, P. S., Long, L. E., Hunt, G. E., Arnold, J. C., & McGregor, I. S. (2010). Residual social, memory and oxytocin-related changes in rats following repeated exposure to Universal-GreekwithMathPi.-1.H9253-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination. Psychopharmacology, 212, 663-674. doi:10.1007/s00213-010-1986-5
46. Vega, C., Moreno-Carranza, B., Zamorano, M., Quintanar-Stephano, A., Mendez, I., Thebault, S.,...Clapp, C. (2010). Prolactin promotes oxytocin and vasopressin release by activating neuronal nitric oxide synthase in the supraoptic and paraventricular nuclei. American Journal of Physiology, Regulatory, Integrative and Comparative Physiology, 299, R1701-R1708. doi:10.1152/ajpregu.00575.2010
47. Wolff, K., Tsapakis, E. M., Winstock, A. R., Hartley, D., Holt, D., Forsling, M. L., & Aitchinson, K. J. (2006). Vasopressin and oxytocin secretion in response to the consumption of ecstasy clubbing population. Journal of Psychopharmacology, 20, 400-410. doi:10.1177/0269881106061514